ORIGINAL RESEARCH article
Front. Microbiol.
Sec. Food Microbiology
Volume 16 - 2025 | doi: 10.3389/fmicb.2025.1577799
This article is part of the Research TopicProbiotics for Global Health: Advances, Applications and ChallengesView all 26 articles
Lactobacillus rhamnosus Glory LG12 preventives loperamide-induced constipation in mice by modulating intestinal flora and metabolic pathways
Provisionally accepted
- College of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Constipation is a common gastrointestinal disease, the incidence of which has been increasing year by year in recent years, and prolonged constipation seriously affects the physical and mental health of patients. Constipation often leads to dysbiosis of the intestinal flora, which in turn exacerbates intestinal dysfunction, and this may be an important mechanism for the development of constipation. Studies have shown that probiotics may be effective in relieving constipation by regulating intestinal flora. Among them, Lactobacillus rhamnosus Glory LG12 (L. rhamnosus Glory LG12), as a potential probiotic strain, has attracted much attention in regulating intestinal flora and improving intestinal function. Although it has shown potential in the treatment of gastrointestinal disorders, its specific role in the treatment of constipation and the related mechanisms are unknown and require in-depth study. In the present study, a mouse model of constipation was constructed by loperamide hydrochlorid. The effect and mechanism of L.rhamnosus Glory LG12 on constipation were investigated by the indicators of water content of defecation, small intestine transit rate, time to the first black stool, defecation and number of grains in 5 h defecation, colonic pathology, inflammatory factors, neurotransmitters, short-chain fatty acids (SCFAs),intestinal flora and other indicators. The results showed that L. rhamnosus Glory LG12 could prevent constipation symptoms to a great extent, and the preventive effect on constipation was more significant with the increasing dose of Lactobacillus rhamnosus. The mechanism of action may be related to the up-regulation of the abundance of Bacteroidota, Firmicutes, Bacteroides, Ligilactobacillus and Parabacteroides in the intestinal flora, the biosynthesis of amino acids, pyrimidine metabolism and other metabolic pathways, the promotion of a variety of glycoside hydrolases, and the increase of short-chain fatty acid content in the defecation of constipated mice.
Keywords: Lactobacillus rhamnosus Glory LG12, Constipation, intestinal flora, short-chain fatty acids, metabolic pathway
Received: 16 Feb 2025; Accepted: 02 Jun 2025.
Copyright: © 2025 Ma, Lian, GUO, Wu and Huang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Lili Huang, College of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.